Autopsy and Case Reports
Autopsy and Case Reports
Article / Clinical Case Report

Malignant paratesticular mesothelioma

Leonardo Gomes da Fonseca; Daniel Fernandes Marques; Tiago Kenji Takahashi; Fernando Nalesso Aguiar; Juliana Naves Ravanini; Daniel Fernandes Saragiotto

Downloads: 6
Views: 1309


Mesothelioma of the tunica vaginalis testis (MTVT) is a rare tumor that usually affects patients after the sixth decade of life. Exposure to asbestos is a known risk factor. Enlargement of the scrotal volume is the most common initial clinical manifestation, and about 15% of cases present metastasis at diagnosis. The treatment relies on surgical resection while the role of adjuvant chemotherapy and radiotherapy remains unclear. The prognosis for patients is generally poor, with a lethal outcome in 30% over a 24-month period. The authors report a case of a 62-year-old patient with the diagnosis of MTVT without a history of asbestos exposure. After surgical treatment, metastatic disease ensued. Chemotherapy was initiated, but could not be continued due to marked and fast clinical deterioration. The authors call attention to the difficulty of early diagnosis of MTVT due to a nonspecific clinical picture, the lack of action by the patient when the scrotal enlargement was first noticed, and the lack of tumor markers. Delayed diagnosis is definitely related to unfavorable prognosis.


Mesothelioma, Chemotherapy, Adjuvant, Spermatic cord, Orchiectomy


Bisceglia M, Bem Dor D, Carosi I, Vario M, Pasquinelli G. Paratesticular mesothelioma. Report of a case with comprehensive review of literacture. Adv Anat Pathol. 2010;17:53-70.

Barbera V, Rubino M. Papillary mesothelioma of the túnica vaginalis. Cancer. 1957;10:183-9. [<183::AID-CNCR2820100127>3.0.CO;2-1]

Meisenkothen C, Finkelstein MM. Asbestos exposure and malignant mesothelioma of the tunica vaginalis testis: Case series and review of the literature. OA Case Reports. 2013;2:17.

Fligiel Z, Kaneko M. Malignant mesothelioma of the tunica vaginalis propria testis in a patient with asbestos exposure. Cancer. 1976;37:1478-84. [<1478::AID-CNCR2820370333>3.0.CO;2-G]

Gurdal M, Erol A. Malignant mesothelioma of tunica vaginalis testis associated with long-lasting hydrocele: could hydrocele be an etiological factor? Int Urol Nephrol. 2001;32:687-9. []

Karunaharan T. Malignant mesothelioma of the tunica vaginalis in an asbestos worker. J R Coll Surg Edinb. 1986;31:253-4.

Huncharek M, Klassen M, Christiani D. Mesothelioma of the tunica vaginalis testis with possible occupational asbestos exposure. Br J Urol. 1995;75:679-80. []

Jones MA, Young RH, Scully RE. Malignant mesothelioma of the tunica vaginalis. Clinicopathologic analysis of 11 cases with review of the literature. Am J Surg Pathol. 1995;19:815-25. []

Plas E, RiedI CR, Pfluger H. Malignant mesothelioma of the tunica vaginalis testis. Review of the literature and assessment of prognostic parameters. Cancer. 1998;83:2437-46. [<2437::AID-CNCR6>3.0.CO;2-G]

Attanoos RL, Gibbs AR. Primary malignant gonadal mesotheliomas and asbestos. Histopathology. 2000; 37:150-9. []

Perez-Ordonez B, Srigley JR. Mesothelial lesions of the paratesticular region. Semin Diagn Pathol. 2000;17:294-306.

Begin R. Asbestos exposure and pleuropulmonary cancer. Rev Mal Respir. 1998;15:723-30.

Peterson JT, Greenberg SD, Buffler PA. Non-asbestos-related malignant mesothelioma. Cancer. 1984;54:951-60. [<951::AID-CNCR2820540536>3.0.CO;2-A]

Taguchi T, Jhanwar S, Siegfried J, Keller SM, Testa JR. Recurrent deletions of specific chromosomal sites in 1p, 3q, 6q and 9q in human malignant mesothelioma. Cancer. 1993;53:4349-55.

Stenton SC. Asbestos, Simian virus 40 and malignant mesothelioma. Thorax. 1996;51:1074-6.

Ascoli V, Facciolo F, Rahimi S, Scalzo CC, Nardi F. Concomitant malignant mesothelioma of the pleura, peritoneum, and tunica vaginalis testis. Diagn Cytopathol. 1996;14:243-8. [<243::AID-DC9>3.0.CO;2-I]

Poggi A, Longo F, Mansueto Get al. A case of mesothelioma of the tunica vaginalis testis, with involvement of the pleura and-peritoneum. Tumori. 2000;86:256-7.

Müller M, Stöckle M, Pecqueux JCet al. Coincident manifestation of mesotheliomas of the tunica vaginalis and pleura. Case report and literature overview. Urologe A. 2008; 47:200-4. []

Antman K, Cohen S, Dimitrov NV, Green M, Muggia F. Malignant mesothelioma of the tunica vaginalis testis. J Clin Oncol. 1984;2:447-51.

Pelzer A, Akkad T, Herwig Ret al. Synchronous bilateral malignant mesothelioma of tunica vaginalis testis: early diagnosis. Urology. 2004;64:1031. []

Sørensen JB, Ravn J, Loft A, Brenøe J, Berthelsen AK; Nordic Mesothelioma Group. Preoperative staging of mesothelioma by 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography fused imaging and mediastinoscopy compared to pathological findings after extrapleural pneumonectomy. Eur J Cardiothorac Surg. 2008; 34:1090-6. []

Wilcox BE, Subramaniam RM, Peller PJet al. Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma. Clin Lung Cancer. 2009;10:244-8. []

Magoha GA. Testicular cancers in Nigerians. East Afr Med J. 1995;72:554-6.

Churg A. Paratesticular mesothelial proliferations. Semin Diagn Pathol. 2003;20:272-8. []

Amin MB. Selected other problematic testicular and paratesticular lesions: rete testis neoplasms and pseudotumors, mesothelial lesions and secondary tumors. Mod Pathol. 2005;18:S131-S145. []

Ordóñez NG. The diagnostic utility of immunohistochemistry and electron microscopy in distinguishing between peritoneal mesotheliomas and serous carcinomas: a comparative study. Mod Pathol. 2006;19:34-48. []

Suster S, Moran CA. Applications and limitations of immunohistochemistry in the diagnosis of malignant mesothelioma. Adv Anat Pathol. 2006;13:316-29. []

Al-Salam S, Hammad FT, Salman MA, AlAshari M. Expression of Wilms tumor-1 protein and CD 138 in malignant mesothelioma of the tunica vaginalis. Pathol Res Pract. 2009;205:797-800. []

Sheibani K, Shin SS, Kezirian J, Weiss LM. Ber-EP4 antibody as a discriminant in the differential diagnosis of malignant mesothelioma versus adenocarcinoma. Am J Surg Pathol. 1991;15:779-84. []

García de Jalon A, Gil P, Azua-Romeo J, Borque A, Sancho C, Rioja LA. Malignant mesothelioma of the tunica vaginalis. Report of a case without risk factors and review of the literature. Int Urol Nephrol. 2003;35:59-62. []

Hassan R, Alexander R. Nonpleural mesotheliomas: meso thelioma of the peritoneum, tunica vaginalis, and pericardium. Hematol Oncol Clin North Am. 2005;19:1067-87. []

Eden CG, Bettochi C, Coker CB, Yates-Bell AJ, Pryor JP. Malignant mesothelioma of the tunica vaginalis. J Urol. 1995;153:1053-4. []

Vogelzang NJ, Rusthoven JJ, Symanowski Jet al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003; 21:2636-44. []

Lee JD, Perez S, Wang HJ, Figlin RA, Holmes EC. Intrapleural chemotherapy for patients with incompletely resected malignant mesothelioma: the UCLA experience. J Surg Oncol. 1995;60:262-7. []

Sebbag J, Yan H, Shmookler B, Suggarbaker P. Malignant mesothelioma of the male genital tract: report of two cases. Urol Oncol. 2001;6:261-4. []


Publication date:

569696af64cc8b5cda711bea autopsy Articles

Autops Case Rep

Share this page
Page Sections